About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:3690015
Allelic
Composition
Tg(Myh6-TNNI3*G203S)4Chs/0
Genetic
Background
Not Specified
Find Mice Using the International Mouse Strain Resource (IMSR)
No mouse lines available in IMSR.
See publication links below for author information.
phenotype observed in females
phenotype observed in males
N normal phenotype
cardiovascular system
• exhibit myofiber disarray in hearts
• markers of hypertrophy are elevated
• develop left ventricle (LV) hypertrophy, with an increase in maximal LV wall thickness and a reduction in LV end-diastolic diameter
• exhibit prolongation of the PR interval, consistent with first-degree atrioventricular block
• exhibit decreased QRS and QRS-H
• cardiomyocytes exhibit abnormal calcium cycling with a prolonged decay constant in calcium transients and a reduced decay constant in response to caffeine treatment, however show normal sarcoplasmic reticulum calcium release and storage
• develop hallmarks of familial hypertrophic cardiomyopathy by 21 weeks of age

muscle
• exhibit myofiber disarray in hearts
• develop left ventricle (LV) hypertrophy, with an increase in maximal LV wall thickness and a reduction in LV end-diastolic diameter
• develop hallmarks of familial hypertrophic cardiomyopathy by 21 weeks of age

growth/size/body
• markers of hypertrophy are elevated
• develop left ventricle (LV) hypertrophy, with an increase in maximal LV wall thickness and a reduction in LV end-diastolic diameter

cellular

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
hypertrophic cardiomyopathy 7 DOID:0110313 OMIM:613690
J:114537


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory